Bao'an, China: net profit in the first half of the year was 680 million yuan, a year-on-year increase of 403%

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Unpacking China | Key Chinese Firms to Watch This Week （26/07/2026-01/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

TikTok Tests Paid Microdrama App LimeShorts in US, Taking On ReelShort and DramaBox

TikTok has been testing a paid standalone microdrama app in the United States called LimeShorts since March, expanding its push into a category dominated by dedicated platforms such as ReelShort and DramaBox.

Mabwell Signs GCC Licensing Deal with Saudi Arabia’s SVAX for Aflibercept Biosimilar

Mabwell (Shanghai) Bioscience Co., Ltd.（迈威（上海）生物科技股份有限公司）has entered into a licensing agreement with Saudi Arabian biopharmaceutical company SVAX Inc. covering its aflibercept biosimilar, 9MW0813, in the Gulf Cooperation Council market.

A Small Aircraft, a Bigger Bet: How China's Worthy Aero Plans to Scale Up

The 115-kilogram amphibious R1 is more than a personal aircraft—it is a testbed for Worthy Aero's larger, hydrogen-powered ambitions.